CPIX241115P7500
- 0.00
- 0.000.00%
Cumberland Pharmaceuticals Newsroom
Cumberland Pharmaceuticals (CPIX.US) will release its financial report after the market closes on November 7th.
Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on November 7th. How was its previous performance? For 2024 Q2, revenue was $9.848849 million, net income was -$-1.102637 million, and eps was -$0.08. For 2023 Q3, revenue was $10.085926 million, net income was -$-1.063219 million, and eps was -$0.07. The above data is presented in accordance with US GAAP. Futubull reminder: 1. Hong Kong stocks, US
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q2 2024 Earnings Conference
Cumberland Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Cumberland Q2 Adj $0.01 Down From $0.16 YoY, Sales $9.85M Down From $10.89M YoY
Express News | Cumberland Pharmaceuticals Inc - on Track to Post Significant Revenue Growth and Positive Cashflow From Operations During 2024
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q2 EPS $0.01
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Posts Q2 Revenue $9.85M
Express News | Cumberland Pharmaceuticals Q2 Operating Expenses USD 10.9 Million
Express News | Cumberland Pharmaceuticals Q2 Revenue USD 9.9 Million
Express News | Cumberland Pharmaceuticals Q2 Net Income USD -1.1 Million
Express News | Cumberland Pharmaceuticals Q2 Adjusted EPS USD 0.01
Express News | Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024
Cumberland Pharma 2Q Loss/Shr 8c >CPIX
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS
The US government's latest move has triggered changes in the US marijuana sector. Biden personally filmed a short video to help
Biden stressed that the policy on reclassification of marijuana was launched at his request.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q1 2024 Earnings Conference
Cumberland Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Cumberland Q1 Adj $(0.05) Down From $0.11 YoY, Sales $8.50M Down From $9.22M YoY